List of Proair Hfa drug patents

Proair Hfa is owned by Teva Branded Pharm.

Proair Hfa contains Albuterol Sulfate.

Proair Hfa has a total of 10 drug patents out of which 0 drug patents have expired.

Proair Hfa was authorised for market use on 29 October, 2004.

Proair Hfa is available in aerosol, metered;inhalation dosage forms.

The generics of Proair Hfa are possible to be released after 01 January, 2032.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7105152 TEVA BRANDED PHARM Suspension aerosol formulations
Sep, 2023

(7 months from now)

US8132712 TEVA BRANDED PHARM Metered-dose inhaler
Sep, 2028

(5 years from now)

US9808587 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(8 years from now)

US10086156 TEVA BRANDED PHARM Dose counter for inhaler and method for counting doses
May, 2031

(8 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(8 years from now)

US11395889 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(8 years from now)

US10022509 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(8 years from now)

US10695512 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(8 years from now)

US9463289 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(8 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(8 years from now)

Drugs and Companies using ALBUTEROL SULFATE ingredient

Market Authorisation Date: 29 October, 2004

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of PROAIR HFA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic